SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.
Blood Adv
2023
7
4
469-481
Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study.
Vasa
2023
52
1
38-45
sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study.
Blood Adv
2023
7
5
832-844
Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300.
Haematologica
2023
108
2
490-501
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts.
Ann Hematol
2023
102
1
99-106
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol
2023
102
2
349-358